Phospho-IGF-I R/IGF1R ELISA DYC1770-2 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemPhospho-IGF-I R/IGF1R ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $495.00Supplier Page View Company Product Page
Catalog NumberDYC1770-2
Quantity1 Kit (for 2 Plates) (also 1 Kit (for 5 Plates), 1 Pack (for 15 Plates))
ApplicationsELISA
ReactivityHuman
Detection TargetIGF-I R/IGF1R
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene Nameinsulin like growth factor 1 receptor
NCBI Gene AliasesCD221, IGFIR, IGFR, JTK13

Available conjugates: Sizes Available: 1 Kit (for 2 Plates) (also 1 Kit (for 5 Plates), 1 Pack (for 15 Plates))

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) Preclinical pharmacology, pharmacokinetics, and pharmacodynamics of veligrotug, a full antagonist antibody to the IGF-1 receptor in development for thyroid eye diseasemAbsDecember 1, 2025Kaplan R, Zhao Y, Tsai J, Dickinson B, Swanson T, Foster K, Bedian V.no. DYC002; Minneapolis, MN) and analyzed using the phospho-IR ELISA kit (R&D Systems, catalog no. DYC1770-2) according to the manufacturer’s protocol. Absorbance at 450 nM was measured using a BioTek Cytation 1

(2) The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian CancerInternational journal of molecular sciencesFebruary 7, 2024Hjortebjerg R, Høgdall C, Hansen KH, Høgdall E, Frystyk J.

(3) Enhanced anti-metastatic bioactivity of an IGF-TRAP re-engineered to improve physicochemical propertiesScientific reportsNovember 26, 2018Vaniotis G, Moffett S, Sulea T, Wang N, Elahi SM, Lessard E, Baardsnes J, Perrino S, Durocher Y, Frystyk J, et al.

(4) Improvement of human keratinocyte migration by a redox active bioelectric dressingPloS oneJanuary 1, 2014Banerjee J, Das Ghatak P, Roy S, Khanna S, Sequin EK, Bellman K, Dickinson BC, Suri P, Subramaniam VV, Chang CJ, et al.

(7) Activated phosphoinositide 3-kinase/AKT signaling confers resistance to trastuzumab but not lapatinibMolecular cancer therapeuticsJune 1, 2010O'Brien NA, Browne BC, Chow L, Wang Y, Ginther C, Arboleda J, Duffy MJ, Crown J, O'Donovan N, Slamon DJ.

(8) Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cellsJournal of cellular and molecular medicineJune 1, 2010Shi P, Chandra J, Sun X, Gergely M, Cortes JE, Garcia-Manero G, Arlinghaus RB, Lai R, Amin HM.cell lines was measured using the human pIGF-IR DuoSet IC ELISA kit as described by the manufacturer (DYC1770–2; R&D Systems). Total proteins of 125 μg were added onto each well. Absorbance was measured at 450 nm

Phospho-IGF-I R/IGF1R ELISA from R&D Systems, a Bio-Techne Brand